Table 2.
| |||||||
---|---|---|---|---|---|---|---|
Fused A-ring | GI50 (μM)a |
||||||
| |||||||
X | Y | Z | A549 | KB | KBvin | DU145 | |
6a | H | CH | CH | 17.8±2.6 | 15.6±1.3 | 17.6±2.5 | 14.8±1.7 |
6b | Me | CH | N | 0.045±0.008 | 0.091±0.009 | 0.055±0.010 | 0.038±0.008 |
6c | Me | N | N | 0.018±0.001 | 0.011±0.001 | 0.018±0.004 | 0.015±0.005 |
6d | Cl | N | N | 0.0017±0.0003 | 0.0017±0.0008 | 0.0017±0.0003 | 0.0015±0.0003 |
6e | NHMe | N | N | 0.027±0.005 | 0.025±0.002 | 0.029±0.005 | 0.023±0.003 |
Paclitaxel b | 0.0076±0.0017 | 0.0064±0.0014 | 1.21±0.19 | 0.006±0.001 |
Concentration of compound that inhibits 50% human tumor cell growth
Positive control.